Complement is activated in progressive multiple sclerosis cortical grey matter lesions
Lewis M. Watkins,James Neal,Samantha Loveless,Iliana Michailidou,Valeria Ramaglia,Mark I. Rees,Richard Reynolds,Neil Robertson,Bryan Paul Morgan,Owain W. Howell,Owain W. Howell +10 more
TL;DR: Complement is activated in the MS cortical grey matter lesions in areas of elevated numbers of complement receptor-positive microglia and suggests that complement over-activation may contribute to the worsening pathology that underlies the irreversible progression of MS.
read more
Abstract: Background
The symptoms of multiple sclerosis (MS) are caused by damage to myelin and nerve cells in the brain and spinal cord. Inflammation is tightly linked with neurodegeneration, and it is the accumulation of neurodegeneration that underlies increasing neurological disability in progressive MS. Determining pathological mechanisms at play in MS grey matter is therefore a key to our understanding of disease progression.
Methods
We analysed complement expression and activation by immunocytochemistry and in situ hybridisation in frozen or formalin-fixed paraffin-embedded post-mortem tissue blocks from 22 progressive MS cases and made comparisons to inflammatory central nervous system disease and non-neurological disease controls.
Results
Expression of the transcript for C1qA was noted in neurons and the activation fragment and opsonin C3b-labelled neurons and glia in the MS cortical and deep grey matter. The density of immunostained cells positive for the classical complement pathway protein C1q and the alternative complement pathway activation fragment Bb was significantly increased in cortical grey matter lesions in comparison to control grey matter. The number of cells immunostained for the membrane attack complex was elevated in cortical lesions, indicating complement activation to completion. The numbers of classical (C1-inhibitor) and alternative (factor H) pathway regulator-positive cells were unchanged between MS and controls, whilst complement anaphylatoxin receptor-bearing microglia in the MS cortex were found closely apposed to cortical neurons. Complement immunopositive neurons displayed an altered nuclear morphology, indicative of cell stress/damage, supporting our finding of significant neurodegeneration in cortical grey matter lesions.
Conclusions
Complement is activated in the MS cortical grey matter lesions in areas of elevated numbers of complement receptor-positive microglia and suggests that complement over-activation may contribute to the worsening pathology that underlies the irreversible progression of MS.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease.
Sebastian Werneburg,Jonathan Jung,Rejani B. Kunjamma,Seung Kwon Ha,Nicholas J. Luciano,Cory M. Willis,Guangping Gao,Natalia P. Biscola,Leif A. Havton,Stephen J. Crocker,Brian Popko,Daniel S. Reich,Dorothy P. Schafer +12 more
TL;DR: Results indicate that microglia eliminate synapses through the alternative complement cascade in demyelinating disease and identify a strategy to prevent synapse loss that may be broadly applicable to other neurodegenerative diseases.
335
The good, the bad, and the opportunities of the complement system in neurodegenerative disease.
TL;DR: Evidence for both beneficial and detrimental effects of complement components and activation products in multiple neurodegenerative disorders are reviewed, as well as the recent studies that support the possibility of successful pharmacological approaches to suppress excessive and detrimental complement-mediated chronic inflammation.
Complement in the pathogenesis of Alzheimer's disease.
TL;DR: How complement may influence the genesis and progression of pathology in Alzheimer’s disease is described, noting the many gaps in understanding and the problems and pitfalls of therapeutic inhibition of complement in the Alzheimer brain.
Microglial phagocytosis of neurons in neurodegeneration, and its regulation.
Claire Ann Butler,Alma S. Popescu,Emily J. A. Kitchener,David H. Allendorf,Mar Puigdellívol,Guy C. Brown +5 more
TL;DR: A review of recent evidence that microglial phagocytosis of live neurons and synapses causes neurodegeneration in animal models of Alzheimer's disease and other tauopathies, Parkinson's disease, frontotemporal dementias, multiple sclerosis, retinal degeneration, and neuro degeneration induced by ischaemia, infection or ageing is presented in this paper.
174
Mechanisms underlying progression in multiple sclerosis.
TL;DR: This review provides an up-to-date overview of the neuropathology of progressive multiple sclerosis, including a summary of the main mechanisms of disease progression, and new therapeutic approaches are emerging outside the modulation of T-cell activity and/or the depletion of B cells.
129
References
The classical complement cascade mediates CNS synapse elimination.
Beth Stevens,Nicola J. Allen,Luis E. Vazquez,Gareth R. Howell,Karen S. Christopherson,Navid Nouri,Kristina D. Micheva,Adrienne K. Mehalow,Andrew D. Huberman,Benjamin K. Stafford,Alexander Sher,Alan Litke,John D. Lambris,Stephen J. Smith,Simon W. M. John,Ben A. Barres +15 more
TL;DR: It is shown that C1q, the initiating protein in the classical complement cascade, is expressed by postnatal neurons in response to immature astrocytes and is localized to synapses throughout the postnatal CNS and retina, supporting a model in which unwanted synapses are tagged by complement for elimination and suggesting that complement-mediated synapse elimination may become aberrantly reactivated in neurodegenerative disease.
3K
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Alexandra Kutzelnigg,Claudia F. Lucchinetti,Christine Stadelmann,Wolfgang Brück,Helmut Rauschka,Markus Bergmann,Manfred Schmidbauer,Joseph E. Parisi,Hans Lassmann +8 more
TL;DR: Global brain pathology in multiple sclerosis is analysed, focusing on the normal-appearing white matter (NAWM) and the cortex, to suggest that multiple sclerosis starts as a focal inflammatory disease of the CNS, which gives rise to circumscribed demyelinated plaques in the white matter.
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
TL;DR: The hypothesis that demyelination, axonal transection, dendritic tran section, and apoptotic loss of neurons in the cerebral cortex contribute to neurological dysfunction in MS patients is supported.
1.4K
Related Papers (5)
Shane A. Liddelow,Kevin A. Guttenplan,Laura E. Clarke,Frederick C. Bennett,Christopher J. Bohlen,Lucas Schirmer,Mariko L. Bennett,Alexandra E. Münch,Won-Suk Chung,Todd C. Peterson,Daniel K. Wilton,Arnaud Frouin,Brooke A. Napier,Nikhil Panicker,Manoj Kumar,Marion S. Buckwalter,David H. Rowitch,Valina L. Dawson,Ted M. Dawson,Beth Stevens,Ben A. Barres +20 more